These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30620026)

  • 1. Live-cell imaging and profiling of c-Jun N-terminal kinases using covalent inhibitor-derived probes.
    Qian L; Pan S; Lee JS; Ge J; Li L; Yao SQ
    Chem Commun (Camb); 2019 Jan; 55(8):1092-1095. PubMed ID: 30620026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of c-Jun N-terminal kinases: an update.
    Koch P; Gehringer M; Laufer SA
    J Med Chem; 2015 Jan; 58(1):72-95. PubMed ID: 25415535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of ASK1 inhibitors.
    Brys R; Gibson K; Poljak T; Van Der Plas S; Amantini D
    Prog Med Chem; 2020; 59():101-179. PubMed ID: 32362327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
    Gehringer M; Muth F; Koch P; Laufer SA
    Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
    Wolle P; Hardick J; Cronin SJF; Engel J; Baumann M; Lategahn J; Penninger JM; Rauh D
    J Med Chem; 2019 Mar; 62(5):2843-2848. PubMed ID: 30768270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
    De SK; Chen V; Stebbins JL; Chen LH; Cellitti JF; Machleidt T; Barile E; Riel-Mehan M; Dahl R; Yang L; Emdadi A; Murphy R; Pellecchia M
    Bioorg Med Chem; 2010 Jan; 18(2):590-6. PubMed ID: 20045647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of c-jun-N-terminal kinase (JNK).
    LoGrasso P; Kamenecka T
    Mini Rev Med Chem; 2008 Jul; 8(8):755-66. PubMed ID: 18673131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
    Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
    Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent and selective covalent inhibitors of JNK.
    Zhang T; Inesta-Vaquera F; Niepel M; Zhang J; Ficarro SB; Machleidt T; Xie T; Marto JA; Kim N; Sim T; Laughlin JD; Park H; LoGrasso PV; Patricelli M; Nomanbhoy TK; Sorger PK; Alessi DR; Gray NS
    Chem Biol; 2012 Jan; 19(1):140-54. PubMed ID: 22284361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
    Lin CW; Yang LY; Shen SC; Chen YC
    J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors.
    De SK; Chen LH; Stebbins JL; Machleidt T; Riel-Mehan M; Dahl R; Chen V; Yuan H; Barile E; Emdadi A; Murphy R; Pellecchia M
    Bioorg Med Chem; 2009 Apr; 17(7):2712-7. PubMed ID: 19282190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents.
    Messoussi A; Feneyrolles C; Bros A; Deroide A; Daydé-Cazals B; Chevé G; Van Hijfte N; Fauvel B; Bougrin K; Yasri A
    Chem Biol; 2014 Nov; 21(11):1433-43. PubMed ID: 25442375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
    Kumar A; Singh UK; Kini SG; Garg V; Agrawal S; Tomar PK; Pathak P; Chaudhary A; Gupta P; Malik A
    Future Med Chem; 2015; 7(15):2065-86. PubMed ID: 26505831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Kamenecka TM; Shin Y; Song X; Jiang R; Noel R; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Khan S; Koenig M; LoGrasso PV
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1719-23. PubMed ID: 21316221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
    Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Ruiz CH; Lograsso PV; Kamenecka TM; Koenig M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):161-4. PubMed ID: 24332487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.